GLP-1s and Skin Conditions

Two inflammatory skin conditions have a genuine relationship with body weight, both are under-treated, and patients with either are rarely told that weight is a modifiable input. I have written about the cosmetic side of skin on these drugs elsewhere; this is the medical side.

Hidradenitis suppurativa

This is the one I most want people to know about, because it is painful, stigmatised, frequently misdiagnosed as recurrent boils for years, and strongly associated with weight.

HS produces recurrent painful nodules, abscesses and sinus tracts in skin folds — armpits, groin, under the breasts, buttocks. It is an inflammatory disease of the hair follicle rather than an infection, though it gets treated as one repeatedly, and the delay to diagnosis commonly runs to 7 years or more.

The association with obesity, smoking and metabolic syndrome is consistent and strong. Observational studies of substantial weight loss report reductions in disease severity, with the largest effects following large losses. The mechanism is plausible on two fronts: friction and moisture in skin folds contribute to the disease process, and adipose tissue is metabolically and inflammatorily active.

What that means practically: if you have HS and obesity, weight loss is one of the few things you can influence that affects the disease. It is an addition to dermatological care — antibiotics, biologics, surgical management — not a replacement for it.

Two cautions specific to this population. Smoking is the other major modifiable factor, and stopping matters at least as much. And loose skin in the affected folds after substantial loss can create new friction and moisture problems, which is a different issue from the HS itself and needs different management.

Psoriasis

The evidence here is stronger in design if smaller in effect.

A randomised clinical trial of dietary weight loss in overweight patients with psoriasis, run over 16 weeks, found improvement in disease severity compared with controls. That is randomised evidence for a lifestyle intervention in a dermatological condition, which is rarer than it should be.

There is a second and more practical reason weight matters, and it gets discussed even less: response to some systemic and biologic therapies is poorer at higher body weight, particularly for agents given at a fixed dose regardless of size. So weight loss can improve how well your existing treatment works, not only act on the disease directly.

Psoriasis also travels with cardiometabolic disease — it is associated with increased cardiovascular risk independent of other factors, which is why the cardiovascular outcome data is relevant to this group rather than incidental.

Do not stop a biologic because your skin improved. That is a dermatology decision, and skin that is clear on treatment is treatment working.

Tell both clinicians

There is no established interaction between GLP-1 receptor agonists and biologics or systemic psoriasis therapies, and the combination is common.

What your dermatologist needs to know is that your weight is changing, because it may change dosing, expected response, and how they interpret a flare or an improvement. And your prescriber should know you have an inflammatory skin condition, because it strengthens the clinical case for treatment — a documented diagnosis with evidence attached is a different coverage argument from a cosmetic one, which is the reasoning in what a GLP-1 actually costs.

The skin problems that come from losing weight

Worth separating clearly, because they get confused with the conditions above.

Intertrigo. Irritation, and sometimes fungal or bacterial overgrowth, in warm moist skin folds. It can appear or worsen during loss, because loosening skin creates new folds and changes where friction happens. Keep the area dry, use a barrier preparation, and treat infection if present — review it at 2 weeks rather than continuing indefinitely — do not treat it indefinitely with a steroid cream.

Skin laxity. Structural, not inflammatory, and no supplement or topical resolves it — best supplements for loose skin.

Hair shedding. Telogen effluvium, appearing 2–4 months after the intake drop, usually self-limiting — best supplements for GLP-1 hair loss.

Facial volume loss. Fat loss, not a skin disease — best supplements for Ozempic face.

Nutritional skin changes. Genuinely worth knowing: zinc, iron, essential fatty acid and B vitamin shortfalls all produce skin and mucosal signs, and intake has halved. Cracking at the corners of the mouth, an unusually dry or scaly rash, or poor wound healing are worth a blood test rather than a moisturiser — reading your own labs.

What to ask for

• If you have recurrent painful lumps in skin folds, ask specifically whether it is hidradenitis suppurativa. It is diagnosed clinically and it is missed for years.
• A dermatology referral if either condition is active and not controlled — weight loss is an addition, not a plan on its own.
• Your dermatologist told that your weight is changing, and by roughly how much.
• Zinc, ferritin and vitamin D checked if new skin or mucosal symptoms appear during rapid loss — zinc has an upper limit of 40 mg a day and should be dosed against a level.
• Smoking cessation support within the first 3 months, if you smoke and have HS. It is the other lever, and it is a large one.